Biobot Analytics logo — Public health analytics powered by wastewater. MIT spin-off...

Biobot Analytics

Public health analytics powered by wastewater. MIT spin-off / Y Combinator W18

Founded 2017 United States Cambridge, United States 31 employees Grant Total: $28.00M Analytics, Big Data +4

General Information

Company Name Biobot Analytics
Founded Year 2017
Location United States Cambridge, United States
Founders / Decision Makers
Team member
Employees 31
Industries Analytics, Big Data, Biotechnology +3
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Biobot Analytics. To contact Biobot Analytics, visit biobot.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biobot Analytics compare?

A PDF of Biobot Analytics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biobot Analytics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biobot Analytics

Biobot Analytics, a startup with a slogan "Public health analytics powered by wastewater" and founded in 2017, is making waves in the public health sphere. Leveraging cutting-edge technology, this MIT spin-off and Y Combinator W18 participant has found a unique way to utilize wastewater as a source of valuable community health data. Their flagship product involves measuring opioids and other drug metabolites in sewage to estimate consumption in cities, thereby providing crucial insights for those working on harm reduction. Their vision is to transform sewers into public health observatories. The company received a grant investment on 21 September 2023 from the National Institute on Drug Abuse (NIDA). Currently headquartered in the United States, Biobot Analytics operates in the realms of Analytics, Big Data, Biotechnology, Health Care, and Water, positioning itself as a significant player at the intersection of health and technology. With their innovative approach, this startup is poised to revolutionize how public health data is gathered and utilized.

Business keywords: public health analytics, wastewater analysis, health data collection, opioid consumption, harm reduction, wastewater epidemiology, data-driven public health, public health infrastructure, MIT spin-off, Y Combinator W18, sewer monitoring, health observatory, epidemiological technology, wastewater-based epidemiology, public health intervention

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
National Institute on Drug Abuse (NIDA)
21 Sep 2023
Series A $20.83M 2
Thursday Ventures, Half Court Ventures
23 Oct 2021
Seed Round $4.20M 5
Y Combinator, DCVC +3
21 Apr 2020
Seed Round $2.50M 10
Soma Capital, Liquid 2 Ventures +8
30 Apr 2018
Pre Seed Round $120.00K 2
Y Combinator, Liquid 2 Ventures
04 Jan 2018
Seed Round $345.00K 4
Hyperplane, Dorm Room Fund +2
15 Dec 2017
Grant Undisclosed 1
MIT delta v
01 Sep 2017
Grant Undisclosed -
20 Jan 2017

Biobot Analytics Alternatives & Competitors

View All Alternatives
Biobot Analytics vs

Innover en santé grâce aux données

Private Equity
26 employees
Analytics, Health Care
Biobot Analytics vs

Combining data science with extensive expertise in research and scientific methodologies.

Venture round
16 employees
Biotechnology, Health Care
Biobot Analytics vs
Black Swan
Black Swan Luxembourg

Blackswan creates real-time predictive anomaly detection using wearable devices for personalized bio...

2-10 employees
AI, Analytics

FAQ About Biobot Analytics

Public health analytics powered by wastewater. MIT spin-off / Y Combinator W18
Biobot Analytics was founded in 2017.
Biobot Analytics is headquartered in Cambridge, United States.
Biobot Analytics operates in Analytics, Big Data, Biotechnology, Health Care, IT and Water. Its work centres on public health analytics, wastewater analysis, health data collection and opioid consumption.
Biobot Analytics has approximately 31 employees.
Biobot Analytics has completed 8 funding rounds, raising a total of $28.00M. The latest funding stage is Grant.
Top alternatives and competitors to Biobot Analytics include OpenHealth Company, Inflexxion powered by Uprise Health, Black Swan, RiAtlas a digital healthcare start-up, OpiSafe. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biobot Analytics and OpenHealth Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biobot Analytics, https://bouncewatch.com/company/biobot-analytics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes